• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,562.90 2,946.32
( 3.95%)
Global Indices
Nasdaq
47,935.11 1,329.65
(2.85%)
Dow Jones
6,804.45 166.60
(2.51%)
Hang Seng
56,345.93 2,916.37
(5.46%)
Nikkei 225
10,596.41 247.62
(2.39%)
Forex
USD-INR
92.93 0.25
(0.27%)
EUR-INR
107.23 0.49
(0.46%)
GBP-INR
122.94 0.71
(0.58%)
JPY-INR
0.58 0.00
(0.32%)

EQUITY - MARKET SCREENER

Nath Bio-Genes (India) Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
537291
INE448G01010
361.6466007
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATHBIOGEN
5.66
279.17
EPS(TTM)
Face Value()
Div & Yield %
25.97
10
1.36
 

sylph technologies ltd
Hindustan Unilever board OKs Rs 2,000-cr capex for capacity expansion
Feb 19,2026
The proposed investment is in line with the company’s strategy of focusing on fewer, bigger bets and strengthening its presence in high-growth demand spaces, including premium skin care and hair care and personal care & home care liquids.

Priya Nair, CEO and managing director, HUL, said: 'This investment reflects our strategic focus on scaling our brands and creating categories of the future to meet evolving consumer needs. It also underscores our commitment to building a resilient, technology-enabled supply chain that delivers superior value to consumers.'

Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.

The company's consolidated net profit zoomed 120.91% to Rs 6,603 crore on 5.74% jump in revenue from operations to Rs 16,235 crore in Q3 FY26 over Q3 FY25.

The counter fell 1.90% to end at Rs 2279.50 on the BSE.